Cryotherapy in acute cutaneous leishmaniasis

Area of Science:

• Dermatology
• Infectious Diseases
• Tropical Medicine

Background:

• Cutaneous leishmaniasis is a parasitic skin infection prevalent in tropical and subtropical regions.
• Current treatments for cutaneous leishmaniasis can have limitations, including side effects and variable efficacy.
• Novel therapeutic approaches are needed to improve patient outcomes.

Purpose of the Study:

• To evaluate the efficacy and safety of liquid nitrogen cryotherapy for treating acute cutaneous leishmaniasis.

Main Methods:

• A study was conducted involving fourteen patients diagnosed with acute cutaneous leishmaniasis.
• Treatment involved the application of liquid nitrogen to all affected skin lesions.
• Patients were monitored for clinical and protozoological cure, adverse effects, and relapse.

Main Results:

• Complete clinical and protozoological cure of all lesions was observed in patients within 3-8 weeks.
• No noticeable scarring was reported following treatment.
• No adverse side effects were experienced by patients, and no relapses occurred within a 4-month follow-up period.

Conclusions:

• Liquid nitrogen cryotherapy demonstrates significant potential as a safe and effective treatment for acute cutaneous leishmaniasis.
• The treatment offers a promising alternative with good cosmetic outcomes and sustained efficacy.
• Further research may support the integration of cryotherapy into standard leishmaniasis treatment protocols.